143 related articles for article (PubMed ID: 8552614)
1. Loss of high-affinity prostacyclin receptors in platelets and the lack of prostaglandin-induced inhibition of platelet-stimulated thrombin generation in subjects with spinal cord injury.
Kahn NN; Bauman WA; Sinha AK
Proc Natl Acad Sci U S A; 1996 Jan; 93(1):245-9. PubMed ID: 8552614
[TBL] [Abstract][Full Text] [Related]
2. Impaired platelet prostacyclin receptor activity: a monozygotic twin study discordant for spinal cord injury.
Kahn N; Sinha A; Bauman W
Clin Physiol; 2001 Jan; 21(1):60-6. PubMed ID: 11168298
[TBL] [Abstract][Full Text] [Related]
3. Demonstration of a novel circulating anti-prostacyclin receptor antibody.
Kahn NN; Bauman WA; Sinha AK
Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8779-82. PubMed ID: 9238054
[TBL] [Abstract][Full Text] [Related]
4. Platelet-stimulated thrombin and PDGF are normalized by insulin and Ca2+ channel blockers.
Kahn NN
Am J Physiol; 1999 May; 276(5):E856-62. PubMed ID: 10329979
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of platelet aggregation and the stimulation of prostacyclin synthesis by insulin in humans.
Kahn NN; Bauman WA; Hatcher VB; Sinha AK
Am J Physiol; 1993 Dec; 265(6 Pt 2):H2160-7. PubMed ID: 8285255
[TBL] [Abstract][Full Text] [Related]
6. Impaired prostaglandin E1/I2 receptor activity of human blood platelets in acute ischemic heart disease.
Kahn NN; Mueller HS; Sinha AK
Circ Res; 1990 Apr; 66(4):932-40. PubMed ID: 2156636
[TBL] [Abstract][Full Text] [Related]
7. Restoration by insulin of impaired prostaglandin E1/I2 receptor activity of platelets in acute ischemic heart disease.
Kahn NN; Mueller HS; Sinha AK
Circ Res; 1991 Jan; 68(1):245-54. PubMed ID: 1845854
[TBL] [Abstract][Full Text] [Related]
8. Platelet prostacyclin binding in coronary artery disease.
Jaschonek K; Karsch KR; Weisenberger H; Tidow S; Faul C; Renn W
J Am Coll Cardiol; 1986 Aug; 8(2):259-66. PubMed ID: 3016061
[TBL] [Abstract][Full Text] [Related]
9. Purification and properties of prostaglandin E1/prostacyclin receptor of human blood platelets.
Dutta-Roy AK; Sinha AK
J Biol Chem; 1987 Sep; 262(26):12685-91. PubMed ID: 2887571
[TBL] [Abstract][Full Text] [Related]
10. Circulating heavy chain IgG, a pathological mediator for coronary artery disease, recognizes platelet surface receptors of both prostacyclin and insulin.
Kahn NN; Bauman WA; Sinha AK
Platelets; 2003 Jun; 14(4):203-10. PubMed ID: 12850828
[TBL] [Abstract][Full Text] [Related]
11. Non-conventional hemostatic risk factors for coronary heart disease in individuals with spinal cord injury.
Khan B; Bauman WA; Sinha AK; Kahn NN
Spinal Cord; 2011 Aug; 49(8):858-66. PubMed ID: 21606930
[TBL] [Abstract][Full Text] [Related]
12. Platelet receptor desensitization induced by elevated prostacyclin levels causes platelet-endothelial cell adhesion.
Darius H; Binz C; Veit K; Fisch A; Meyer J
J Am Coll Cardiol; 1995 Sep; 26(3):800-6. PubMed ID: 7543911
[TBL] [Abstract][Full Text] [Related]
13. Refractoriness of platelets to prostaglandins after infusion in rabbits.
Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E
J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353
[TBL] [Abstract][Full Text] [Related]
14. Prostacyclin receptor desensitization is a reversible phenomenon in human platelets.
Fisch A; Tobusch K; Veit K; Meyer J; Darius H
Circulation; 1997 Aug; 96(3):756-60. PubMed ID: 9264479
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of prostaglandin E1 binding to human blood platelet membrane by insulin and the activation of adenylate cyclase.
Kahn NN; Sinha AK
J Biol Chem; 1990 Mar; 265(9):4976-81. PubMed ID: 1969414
[TBL] [Abstract][Full Text] [Related]
16. The single prostacyclin receptor of gel-filtered platelets provides a correlation with antiaggregatory potency of PGI2 mimics.
Eggerman TL; Hartzell CJ; Selfe S; Andersen NH
Thromb Res; 1987 Mar; 45(5):645-59. PubMed ID: 3296302
[TBL] [Abstract][Full Text] [Related]
17. The use of a prostacyclin analogue, [3H]iloprost, for studying prostacyclin-binding sites on human platelets and neuronal hybrid cells.
Hall JM; Strange PG
Biosci Rep; 1984 Nov; 4(11):941-8. PubMed ID: 6084527
[TBL] [Abstract][Full Text] [Related]
18. Octimibate inhibition of platelet aggregation: stimulation of adenylate cyclase through prostacyclin receptor activation.
Seiler S; Brassard CL; Arnold AJ; Meanwell NA; Fleming JS; Keely SL
J Pharmacol Exp Ther; 1990 Dec; 255(3):1021-6. PubMed ID: 2175792
[TBL] [Abstract][Full Text] [Related]
19. Comparison of equimolar concentrations of iloprost, prostacyclin, and prostaglandin E1 on human platelet function.
Fisher CA; Kappa JR; Sinha AK; Cottrell ED; Reiser HJ; Addonizio VP
J Lab Clin Med; 1987 Feb; 109(2):184-90. PubMed ID: 2433373
[TBL] [Abstract][Full Text] [Related]
20. Prostacyclin-sensitive adenylate cyclase and prostacyclin binding sites in platelets and smooth muscle cells.
Nicosia S; Oliva D; Bernini F; Fumagalli R
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():593-9. PubMed ID: 6328938
[No Abstract] [Full Text] [Related]
[Next] [New Search]
